Hu EH - Search Results

1

A phase II trial of frontline capecitabine and bevacizumab in poor performance status and/or elderly patients with metastatic colorectal cancer.

Naeim A, Ward PR, Wang HJ, Dichmann R, Liem AK, Chan D, Patel R, Hu EH, Tchekmedyian NS, Wainberg ZA, Hecht JR. Naeim A, et al. Among authors: hu eh. J Geriatr Oncol. 2013 Oct;4(4):302-9. doi: 10.1016/j.jgo.2013.05.001. Epub 2013 Jun 7. J Geriatr Oncol. 2013. PMID: 24472472 Clinical Trial.

2

Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: an exploratory analysis.

Ward P, Hecht JR, Wang HJ, Dichmann R, Liem AK, Chan D, Patel R, Hu EH, Tchekmedyian NS, Wainberg ZA, Naeim A. Ward P, et al. Among authors: hu eh. J Geriatr Oncol. 2014 Oct 1;5(4):368-75. doi: 10.1016/j.jgo.2014.05.002. Epub 2014 Jul 4. J Geriatr Oncol. 2014. PMID: 25002322 Clinical Trial.

3

Possible Epstein-Barr virus encephalitis in an elderly patient.

Hu E, Chan DK. Hu E, et al. Aust N Z J Med. 2000 Apr;30(2):282. doi: 10.1111/j.1445-5994.2000.tb00825.x. Aust N Z J Med. 2000. PMID: 10833128 No abstract available.

4

A phase 1a clinical trial of LYM-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies.

Hu E, Epstein AL, Naeve GS, Gill I, Martin S, Sherrod A, Nichols P, Chen D, Mazumder A, Levine AM. Hu E, et al. Hematol Oncol. 1989 Mar-Apr;7(2):155-66. doi: 10.1002/hon.2900070207. Hematol Oncol. 1989. PMID: 2784122

5

Phase I toxicity and pharmacology study of trimethylcolchicinic acid in patients with advanced malignancies.

Hu E, Ko R, Koda R, Rosen P, Jeffers S, Scholtz M, Muggia F. Hu E, et al. Cancer Chemother Pharmacol. 1990;26(5):359-64. doi: 10.1007/BF02897294. Cancer Chemother Pharmacol. 1990. PMID: 2208579

6

Phase I study of combination recombinant interleukin-2 and interferon gamma in patients with advanced malignancies.

Hu E, Watkins K, Groshen S, Chen SC, Malloy B, Agah R, Nichols P, Parker J, Martin A, Boosalis MG, et al. Hu E, et al. Mol Biother. 1990 Jun;2(2):96-103. Mol Biother. 1990. PMID: 2114123

7

Validating a screening questionnaire for parkinsonism in Australia.

Chan DK, Hung WT, Wong A, Hu E, Beran RG. Chan DK, et al. J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):117-20. doi: 10.1136/jnnp.69.1.117. J Neurol Neurosurg Psychiatry. 2000. PMID: 10864617 Free PMC article.

8

Active-specific immunotherapy for melanoma.

Mitchell MS, Harel W, Kempf RA, Hu E, Kan-Mitchell J, Boswell WD, Dean G, Stevenson L. Mitchell MS, et al. J Clin Oncol. 1990 May;8(5):856-69. doi: 10.1200/JCO.1990.8.5.856. J Clin Oncol. 1990. PMID: 2139701

9

Pilot study of prevalence of Parkinson's disease in Australia.

Chan DK, Dunne M, Wong A, Hu E, Hung WT, Beran RG. Chan DK, et al. Neuroepidemiology. 2001 May;20(2):112-7. doi: 10.1159/000054769. Neuroepidemiology. 2001. PMID: 11359078

10

Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodies.

DeNardo SJ, DeNardo GL, O'Grady LF, Hu E, Sytsma VM, Mills SL, Levy NB, Macey DJ, Miller CH, Epstein AL. DeNardo SJ, et al. Int J Cancer Suppl. 1988;3:96-101. Int J Cancer Suppl. 1988. PMID: 3209308

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters